Adults aged 18 and over presenting with diarrhea after recent international travel represent a distinct clinical population. Travel destination is central to guiding assessment and management in this setting.
This protocol covers adults (age ≥ 18) who develop traveler's diarrhea in the context of recent international travel. The travel history — including destination and regional susceptibility patterns — is a key factor in determining the appropriate clinical approach.
Current evidence supports empiric antimicrobial therapy for eligible adults in this setting, with the choice of agent informed by local susceptibility patterns and travel history.